Louisbourg Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Louisbourg Investments's RPRX Position: Q2 2026 in Review
Louisbourg Investments opened a new position in Royalty Pharma (RPRX) in Q2 2026: 502 shares worth $28.1K. The stake represents 0.01% of the portfolio and ranks #152 among its holdings. This is a return to the name: Louisbourg Investments previously reported a position in RPRX as recently as Q1 2025.
Louisbourg Investments first reported a position in RPRX in Q1 2025 and has held it in 2 quarters since. The position peaked at $28.2K in Q1 2025. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Louisbourg Investments held 502 shares of Royalty Pharma worth $28.1K as of Q2 2026.
- Royalty Pharma was a new Louisbourg Investments position in Q2 2026.
- Royalty Pharma made up 0.01% of Louisbourg Investments's portfolio in Q2 2026, its #152 holding.
- Louisbourg Investments first reported a position in Royalty Pharma in Q1 2025 and has held it in 2 quarters since.
- Louisbourg Investments's Royalty Pharma position peaked at $28.2K in Q1 2025.
- 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.